During the past decade, Columbia University Medical Center: Department of Medicine, Division of Rheumatology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Medical Center: Department of Medicine, Division of Rheumatology" #1 collaborator was "Autoimmunity Centers of Excellence" with 1 trials as a collaborator, "Corbus Pharmaceuticals Inc." with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center: Department of Medicine, Division of Rheumatology" are "Systemic Lupus Erythematosus" (2 trials), "Lupus" (1 trials), "Lupus Nephritis" (1 trials) and "SLE" (1 trials). Many other conditions were trialed in "Columbia University Medical Center: Department of Medicine, Division of Rheumatology" in a lesser frequency.

Most popular intervention types in "Columbia University Medical Center: Department of Medicine, Division of Rheumatology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "JBT-101" (1 trials), "Mycophenolate Mofetil" (1 trials), "Placebo" (1 trials), "Placebo for Mycophenolate Mofetil" (1 trials) and "Placebo for VIB4920" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Medical Center: Department of Medicine, Division of Rheumatology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Columbia University Medical Center: Department of Medicine, Division of Rheumatology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Columbia University Medical Center: Department of Medicine, Division of Rheumatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Medical Center: Department of Medicine, Division of Rheumatology, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".